Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hanrath

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
European Heart Journal|August 4, 2004
Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stentFelix Vogt, Andreas Stein, Gösta Rettemeier, et al.
European Journal of Heart Failure|May 30, 2002
Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMETPhilip A Poole-Wilson, John G F Cleland, Andrea Di Lenarda, et al.
European Heart Journal|March 25, 2004
The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosisJan R Ortlepp, Fabian Schmitz, Vera Mevissen, et al.
Pacing and Clinical Electrophysiology : PACE|May 6, 2004
Postfibrillatory enhancement of left atrial contractility after short paroxysms of atrial fibrillationMarkus Zarse, Patrick Schauerte, Georg Mülenbruch, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 11, 2002
Intravenous myocardial contrast echocardiography predicts left ventricular remodeling in patients with acute myocardial infarctionWolfgang Lepper, Otto Kamp, Jean Louis Vanoverschelde, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 12, 2008
Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillationChristian Knackstedt, Felix Gramley, Thomas Schimpf, et al.
International Journal of Cardiology|October 7, 2005
Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 yearsJan R Ortlepp, Constanze Krantz, Melanie Kimmel, et al.
Cardiac Electrophysiology Review|April 9, 2004
Use of subcutaneous enoxaparin compared to intravenous heparin and oral phenprocoumon in the setting of cardioversion--the ACE study (Anticoagulation in Cardioversion using Enoxaparin)Christoph Stellbrink, Uwe Nixdorff, Thomas Hofmann, et al.
Circulation|February 18, 2004
Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trialChristoph Stellbrink, Uwe Nixdorff, Thomas Hofmann, et al.
Journal of the American College of Cardiology|April 17, 2002
Repeated assessment of coronary flow velocity pattern in patients with first acute myocardial infarctionWolfgang Lepper, Gertjan Tj Sieswerda, Andreas Franke, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
European Heart Journal|August 4, 2004
Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stentFelix Vogt, Andreas Stein, Gösta Rettemeier, et al.
European Journal of Heart Failure|May 30, 2002
Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMETPhilip A Poole-Wilson, John G F Cleland, Andrea Di Lenarda, et al.
European Heart Journal|March 25, 2004
The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosisJan R Ortlepp, Fabian Schmitz, Vera Mevissen, et al.
Pacing and Clinical Electrophysiology : PACE|May 6, 2004
Postfibrillatory enhancement of left atrial contractility after short paroxysms of atrial fibrillationMarkus Zarse, Patrick Schauerte, Georg Mülenbruch, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 11, 2002
Intravenous myocardial contrast echocardiography predicts left ventricular remodeling in patients with acute myocardial infarctionWolfgang Lepper, Otto Kamp, Jean Louis Vanoverschelde, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|April 12, 2008
Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillationChristian Knackstedt, Felix Gramley, Thomas Schimpf, et al.
International Journal of Cardiology|October 7, 2005
Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 yearsJan R Ortlepp, Constanze Krantz, Melanie Kimmel, et al.
Cardiac Electrophysiology Review|April 9, 2004
Use of subcutaneous enoxaparin compared to intravenous heparin and oral phenprocoumon in the setting of cardioversion--the ACE study (Anticoagulation in Cardioversion using Enoxaparin)Christoph Stellbrink, Uwe Nixdorff, Thomas Hofmann, et al.
Circulation|February 18, 2004
Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trialChristoph Stellbrink, Uwe Nixdorff, Thomas Hofmann, et al.
Journal of the American College of Cardiology|April 17, 2002
Repeated assessment of coronary flow velocity pattern in patients with first acute myocardial infarctionWolfgang Lepper, Gertjan Tj Sieswerda, Andreas Franke, et al.
Pageof 12